SARS vaccine: progress and challenge.
Identifieur interne : 004658 ( Main/Exploration ); précédent : 004657; suivant : 004659SARS vaccine: progress and challenge.
Auteurs : Yan Zhi [États-Unis] ; James M. Wilson ; Hao ShenSource :
- Cellular & molecular immunology [ 1672-7681 ] ; 2005.
Descripteurs français
- KwdFr :
- Animaux, Flambées de maladies (), Humains, Modèles animaux de maladie humaine, Syndrome respiratoire aigu sévère (), Syndrome respiratoire aigu sévère (immunologie), Syndrome respiratoire aigu sévère (épidémiologie), Vaccins antiviraux (génétique), Vaccins antiviraux (immunologie), Vaccins antiviraux (isolement et purification), Virus du SRAS (immunologie).
- MESH :
- génétique : Vaccins antiviraux.
- immunologie : Syndrome respiratoire aigu sévère, Vaccins antiviraux, Virus du SRAS.
- isolement et purification : Vaccins antiviraux.
- épidémiologie : Syndrome respiratoire aigu sévère.
- Animaux, Flambées de maladies, Humains, Modèles animaux de maladie humaine, Syndrome respiratoire aigu sévère.
English descriptors
- KwdEn :
- Animals, Disease Models, Animal, Disease Outbreaks (prevention & control), Humans, SARS Virus (immunology), Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (immunology), Severe Acute Respiratory Syndrome (prevention & control), Viral Vaccines (genetics), Viral Vaccines (immunology), Viral Vaccines (isolation & purification).
- MESH :
- chemical , genetics : Viral Vaccines.
- epidemiology : Severe Acute Respiratory Syndrome.
- immunology : SARS Virus, Severe Acute Respiratory Syndrome, Viral Vaccines.
- chemical , isolation & purification : Viral Vaccines.
- prevention & control : Disease Outbreaks, Severe Acute Respiratory Syndrome.
- Animals, Disease Models, Animal, Humans.
Abstract
Severe acute respiratory syndrome (SARS) emerged in 2002 as a severe and highly contagious infectious disease that rapidly spread to a number of different countries. The collaborative efforts of the global scientific community have provided, within a short period of time, substantial insights into the molecular biology and immunology of SARS-CoV. Although the outbreak has been contained, there is continuous concern that the virus may resurface into the human population through seasonal changes, animal reservoirs or laboratory accidents. The severe morbidity and mortality associated with SARS make it imperative that an effective vaccine be developed to prevent reemergence and epidemics in the future.
PubMed: 16191415
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002522
- to stream PubMed, to step Curation: 002522
- to stream PubMed, to step Checkpoint: 002518
- to stream Ncbi, to step Merge: 001182
- to stream Ncbi, to step Curation: 001182
- to stream Ncbi, to step Checkpoint: 001182
- to stream Main, to step Merge: 004923
- to stream Main, to step Curation: 004658
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">SARS vaccine: progress and challenge.</title>
<author><name sortKey="Zhi, Yan" sort="Zhi, Yan" uniqKey="Zhi Y" first="Yan" last="Zhi">Yan Zhi</name>
<affiliation wicri:level="2"><nlm:affiliation>Gene Therapy Program, Division of Medical Genetics, Department of Medicine, University of Pennsylvania Health System, Philadelphia, PA 19104, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Gene Therapy Program, Division of Medical Genetics, Department of Medicine, University of Pennsylvania Health System, Philadelphia, PA 19104</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wilson, James M" sort="Wilson, James M" uniqKey="Wilson J" first="James M" last="Wilson">James M. Wilson</name>
</author>
<author><name sortKey="Shen, Hao" sort="Shen, Hao" uniqKey="Shen H" first="Hao" last="Shen">Hao Shen</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:16191415</idno>
<idno type="pmid">16191415</idno>
<idno type="wicri:Area/PubMed/Corpus">002522</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002522</idno>
<idno type="wicri:Area/PubMed/Curation">002522</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002522</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002518</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002518</idno>
<idno type="wicri:Area/Ncbi/Merge">001182</idno>
<idno type="wicri:Area/Ncbi/Curation">001182</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001182</idno>
<idno type="wicri:doubleKey">1672-7681:2005:Zhi Y:sars:vaccine:progress</idno>
<idno type="wicri:Area/Main/Merge">004923</idno>
<idno type="wicri:Area/Main/Curation">004658</idno>
<idno type="wicri:Area/Main/Exploration">004658</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">SARS vaccine: progress and challenge.</title>
<author><name sortKey="Zhi, Yan" sort="Zhi, Yan" uniqKey="Zhi Y" first="Yan" last="Zhi">Yan Zhi</name>
<affiliation wicri:level="2"><nlm:affiliation>Gene Therapy Program, Division of Medical Genetics, Department of Medicine, University of Pennsylvania Health System, Philadelphia, PA 19104, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Gene Therapy Program, Division of Medical Genetics, Department of Medicine, University of Pennsylvania Health System, Philadelphia, PA 19104</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wilson, James M" sort="Wilson, James M" uniqKey="Wilson J" first="James M" last="Wilson">James M. Wilson</name>
</author>
<author><name sortKey="Shen, Hao" sort="Shen, Hao" uniqKey="Shen H" first="Hao" last="Shen">Hao Shen</name>
</author>
</analytic>
<series><title level="j">Cellular & molecular immunology</title>
<idno type="ISSN">1672-7681</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Disease Outbreaks (prevention & control)</term>
<term>Humans</term>
<term>SARS Virus (immunology)</term>
<term>Severe Acute Respiratory Syndrome (epidemiology)</term>
<term>Severe Acute Respiratory Syndrome (immunology)</term>
<term>Severe Acute Respiratory Syndrome (prevention & control)</term>
<term>Viral Vaccines (genetics)</term>
<term>Viral Vaccines (immunology)</term>
<term>Viral Vaccines (isolation & purification)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Flambées de maladies ()</term>
<term>Humains</term>
<term>Modèles animaux de maladie humaine</term>
<term>Syndrome respiratoire aigu sévère ()</term>
<term>Syndrome respiratoire aigu sévère (immunologie)</term>
<term>Syndrome respiratoire aigu sévère (épidémiologie)</term>
<term>Vaccins antiviraux (génétique)</term>
<term>Vaccins antiviraux (immunologie)</term>
<term>Vaccins antiviraux (isolement et purification)</term>
<term>Virus du SRAS (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term>
<term>Vaccins antiviraux</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
<term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Viral Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Vaccins antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Disease Outbreaks</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Flambées de maladies</term>
<term>Humains</term>
<term>Modèles animaux de maladie humaine</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Severe acute respiratory syndrome (SARS) emerged in 2002 as a severe and highly contagious infectious disease that rapidly spread to a number of different countries. The collaborative efforts of the global scientific community have provided, within a short period of time, substantial insights into the molecular biology and immunology of SARS-CoV. Although the outbreak has been contained, there is continuous concern that the virus may resurface into the human population through seasonal changes, animal reservoirs or laboratory accidents. The severe morbidity and mortality associated with SARS make it imperative that an effective vaccine be developed to prevent reemergence and epidemics in the future.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Pennsylvanie</li>
</region>
</list>
<tree><noCountry><name sortKey="Shen, Hao" sort="Shen, Hao" uniqKey="Shen H" first="Hao" last="Shen">Hao Shen</name>
<name sortKey="Wilson, James M" sort="Wilson, James M" uniqKey="Wilson J" first="James M" last="Wilson">James M. Wilson</name>
</noCountry>
<country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Zhi, Yan" sort="Zhi, Yan" uniqKey="Zhi Y" first="Yan" last="Zhi">Yan Zhi</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004658 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004658 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:16191415 |texte= SARS vaccine: progress and challenge. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:16191415" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |